Talecris announces publication of PROLASTIN-C study results for AAT deficiency in BML journal
Links shared publicly online about this topic.
- 783total visits
Talecris announces publication of PROLASTIN-C study results for AAT deficiency in BML journal
Talecris Biotherapeutics today announced the publication of results from a study showing that PROLASTIN-C (Alpha1-Proteinase Inhibitor [Human]) (A1PI) is as effective as PROLASTIN (Alpha1-Proteinase Inhibitor [Human]) in raising levels of alpha-1 protein in patients with alpha1-antitrypsin (AAT) deficiency.
View full resource at news-medical.net
Tags: Protein, Health Insurance, Medicare, News
Most Recently Shared on October 22, 2010 at 9:34 am By:
Medicare News: Talecris announces publication of PROLASTIN-C study results for AAT deficiency in BML journal: Tale... http://bit.ly/9sPgSI
Advertisement
